EP3599237
PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.11.2010:
24.3.2021:
19182732.8
:
23.11.2030
:
PHARMACEUTICAL COMPOSITION OF THE GLUCOSYLCERAMIDE SYNTHASE INHIBITOR ELIGLUSTAT FOR THE TREATMENT OF GAUCHER'S DISEASE COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P450 METABOLISM OF THE PATIENT
24.11.2010
24.3.2021
:
Genzyme Corporation:
50 Binney Street, Cambridge, MA 02142, US
:
LIU, Hanlan:
Lexington, MA Massachusetts 02420, US
:
WILLIS, Chris:
Southborough, MA Massachusetts 01772, US
:
BHARDWAJ, Renu:
Ashland, MA Massachusetts 01721, US
:
COPELAND, Diane P.:
Billerica, MA Massachusetts 01862, US
:
HARIANAWALA, Abizer:
Acton, MA Massachusetts 01720, US
:
SKELL, Jeffrey:
Westborough, MA Massachusetts 01581, US
:
MARSHALL, John:
Bridgewater, NJ New Jersey 08807, US
:
KOCHLING, Jianmei:
Wellesley, MA Massachusetts 02482, US
:
PALACE, Gerard:
Framingham, MA Massachusetts 01701, US
:
PETERSCHMITT, Judith:
Watertown, MA Massachusetts 02472, US
:
SIEGEL, Craig:
Woburn, MA Massachusetts 01801, US
:
CHENG, Seng:
Natick, MA Massachusetts 01760, US
:
26474809 P:
27.11.2009:
US
:
C07D 405/06, C07D 319/16, A61K 31/4025, A61P 35/00